2359.HK vs. 1801.HK

Last updated Apr 3, 2026

Compare and contrast key facts about WuXi AppTec Co Ltd H (2359.HK) and Innovent Biologics Inc (1801.HK).

Performance

2359.HK vs. 1801.HK - Performance Comparison

The chart below illustrates the hypothetical performance of a HK$10,000 investment in WuXi AppTec Co Ltd H (2359.HK) and Innovent Biologics Inc (1801.HK). The values are adjusted to include any dividend payments, if applicable.

2359.HK vs. 1801.HK - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018
2359.HK WuXi AppTec Co Ltd H	26.55%	78.20%	-26.51%	-2.22%	-38.51%	7.01%	120.88%	101.05%	-0.00%
1801.HK Innovent Biologics Inc	20.00%	108.33%	-14.39%	27.61%	-30.57%	-41.19%	209.04%	10.17%	12.88%

Returns By Period

In the year-to-date period, 2359.HK achieves a 26.55% return, which is significantly higher than 1801.HK's 20.00% return.

2359.HK

• 1D: 0.81%
• 1M: 11.12%
• YTD: 26.55%
• 6M: 2.88%
• 1Y: 85.86%
• 3Y*: 17.91%
• 5Y*: -0.09%
• 10Y*: —

1801.HK

• 1D: 0.66%
• 1M: 14.30%
• YTD: 20.00%
• 6M: -9.14%
• 1Y: 83.55%
• 3Y*: 37.89%
• 5Y*: 2.51%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

2359.HK vs. 1801.HK — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

2359.HK

2359.HK Risk / Return Rank: 83
2359.HK Sharpe Ratio Rank: 86
2359.HK Sortino Ratio Rank: 81
2359.HK Omega Ratio Rank: 81
2359.HK Calmar Ratio Rank: 82
2359.HK Martin Ratio Rank: 84

1801.HK

1801.HK Risk / Return Rank: 83
1801.HK Sharpe Ratio Rank: 83
1801.HK Sortino Ratio Rank: 78
1801.HK Omega Ratio Rank: 78
1801.HK Calmar Ratio Rank: 91
1801.HK Martin Ratio Rank: 86

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

2359.HK vs. 1801.HK - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for WuXi AppTec Co Ltd H (2359.HK) and Innovent Biologics Inc (1801.HK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	2359.HK	1801.HK	Difference
Sharpe ratio Return per unit of total volatility	1.73	1.50	+0.23
Sortino ratio Return per unit of downside risk	2.21	2.09	+0.12
Omega ratio Gain probability vs. loss probability	1.30	1.28	+0.02
Calmar ratio Return relative to maximum drawdown	2.82	4.65	-1.84
Martin ratio Return relative to average drawdown	7.95	9.12	-1.17
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

2359.HK vs. 1801.HK - Sharpe Ratio Comparison

The current 2359.HK Sharpe Ratio is 1.73, which is comparable to the 1801.HK Sharpe Ratio of 1.50. The chart below compares the historical Sharpe Ratios of 2359.HK and 1801.HK, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	2359.HK	1801.HK	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.73	1.50	+0.23
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.00	0.04	-0.04
Sharpe Ratio (All Time) Calculated using the full available price history	0.43	0.45	-0.01

Correlation

The correlation between 2359.HK and 1801.HK is 0.49, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.

Dividends

2359.HK vs. 1801.HK - Dividend Comparison

2359.HK's dividend yield for the trailing twelve months is around 1.15%, while 1801.HK has not paid dividends to shareholders.

	TTM	2025	2024	2023	2022	2021	2020	2019
2359.HK WuXi AppTec Co Ltd H	1.15%	1.46%	1.92%	1.24%	0.75%	0.39%	0.34%	0.96%
1801.HK Innovent Biologics Inc	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Drawdowns

2359.HK vs. 1801.HK - Drawdown Comparison

The maximum 2359.HK drawdown since its inception was -84.67%, roughly equal to the maximum 1801.HK drawdown of -82.01%. Use the drawdown chart below to compare losses from any high point for 2359.HK and 1801.HK.

Drawdown Indicators

	2359.HK	1801.HK	Difference
Max Drawdown Largest peak-to-trough decline	-84.67%	-82.01%	-2.66%
Max Drawdown (1Y) Largest decline over 1 year	-24.55%	-28.74%	+4.19%
Max Drawdown (5Y) Largest decline over 5 years	-84.67%	-80.16%	-4.51%
Current Drawdown Current decline from peak	-29.24%	-14.49%	-14.75%
Average Drawdown Average peak-to-trough decline	-36.80%	-38.29%	+1.49%
Ulcer Index Depth and duration of drawdowns from previous peaks	11.02%	14.66%	-3.64%

Volatility

2359.HK vs. 1801.HK - Volatility Comparison

The current volatility for WuXi AppTec Co Ltd H (2359.HK) is 14.26%, while Innovent Biologics Inc (1801.HK) has a volatility of 16.60%. This indicates that 2359.HK experiences smaller price fluctuations and is considered to be less risky than 1801.HK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	2359.HK	1801.HK	Difference
Volatility (1M) Calculated over the trailing 1-month period	14.26%	16.60%	-2.34%
Volatility (6M) Calculated over the trailing 6-month period	31.17%	34.63%	-3.46%
Volatility (1Y) Calculated over the trailing 1-year period	51.39%	57.52%	-6.13%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	61.12%	62.08%	-0.96%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	56.59%	59.72%	-3.13%

Financials